» Articles » PMID: 29448189

3-(E)-Styryl-2H-chromene Derivatives As Potent and Selective Monoamine Oxidase B Inhibitors

Overview
Journal Bioorg Chem
Publisher Elsevier
Specialties Biochemistry
Chemistry
Date 2018 Feb 16
PMID 29448189
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A series of novel 3-(E)-styryl-2H-chromene derivatives were synthesized and their monoamine oxidase (MAO) A and B inhibitory activities were evaluated. All compounds exhibited no inhibitory activity towards MAO-A at 10 μM whereas compounds 1-5, 7, 9, 11-13, 15 and 16 showed strong inhibitory activity towards MAO-B at this concentration. Of these, compound 3, which contains fluorine at R, showed the highest activity (IC = 10 nM), and is about 22-fold more potent than pargyline (used as a positive control). Quantitative structure-activity relationship (QSAR) analyses of 3-(E)-styryl-2H-chromene derivatives were conducted using Molecular Operating Environment (MOE). QSAR analyses of 3-(E)-styryl-2H-chromene derivatives with pIC values for MAO-B demonstrated that 140 descriptors showed significant correlations. The strongly correlated descriptors indicated that properties such as molecular shape, size, and hydrophobicity, as well as the functional groups, of 3-(E)-styryl-2H-chromene derivatives are important for their inhibitory activity. This is the first report identifying 3-(E)-styryl-2H-chromene derivatives as potent and selective MAO-B inhibitors. These results suggest that the 3-(E)-styryl-2H-chromene structure may be a useful scaffold for the design and development of novel monoamine oxidase inhibitors.

Citing Articles

The Chromenopyridine Scaffold: A Privileged Platform in Drug Design.

Pedroso de Lima F, Costa M, Sousa A, Proenca M Molecules. 2024; 29(13).

PMID: 38998955 PMC: 11243271. DOI: 10.3390/molecules29133004.


Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors.

Kumar S, Bhowmik R, Oh J, Abdelgawad M, Ghoneim M, Al-Serwi R Sci Rep. 2024; 14(1):4868.

PMID: 38418571 PMC: 10901862. DOI: 10.1038/s41598-024-55628-y.


Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma.

Sugita Y, Takao K, Uesawa Y, Nagai J, Iijima Y, Sano M Medicines (Basel). 2020; 7(9).

PMID: 32858984 PMC: 7555025. DOI: 10.3390/medicines7090050.


2H/4H-Chromenes-A Versatile Biologically Attractive Scaffold.

Raj V, Lee J Front Chem. 2020; 8:623.

PMID: 32850645 PMC: 7419998. DOI: 10.3389/fchem.2020.00623.


Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs.

Hagenow J, Hagenow S, Grau K, Khanfar M, Hefke L, Proschak E Drug Des Devel Ther. 2020; 14:371-393.

PMID: 32099324 PMC: 6996489. DOI: 10.2147/DDDT.S236586.